Title:
Development of a controlled-release platform for investigation of proteases following rotator cuff tear

dc.contributor.advisor Temenoff, Johnna S.
dc.contributor.author Trevino, Elda Alicia
dc.contributor.committeeMember Platt, Manu O.
dc.contributor.committeeMember Willett, Nick J.
dc.contributor.committeeMember Botchwey, Edward A.
dc.contributor.committeeMember Drissi, Hicham
dc.contributor.department Biomedical Engineering (Joint GT/Emory Department)
dc.date.accessioned 2020-09-08T12:46:22Z
dc.date.available 2020-09-08T12:46:22Z
dc.date.created 2020-08
dc.date.issued 2020-07-08
dc.date.submitted August 2020
dc.date.updated 2020-09-08T12:46:22Z
dc.description.abstract Surgical reattachment of torn rotator cuff tendons has a high rate of re-tear (failure) and the procedure does not reverse joint tissue degeneration present at the time of surgery. Following rotator cuff tear, three different joint tissues (tendon, muscle, and articular cartilage) develop degenerative changes. A possible cause for the extensive joint tissue degeneration observed following rotator cuff tear is the prolonged activation of proteases, which are specialized enzymes whose primary function is to degrade proteins. Systemic delivery of several protease inhibitors have been tested in human clinical trials to for a variety of diseases including osteoarthritis and osteoporosis, but all have been abandoned due to off-target effects. However, local delivery of protease inhibitors could reduce disease progression without deleterious side effects. The long-term goal of this dissertation was to understand how proteases contribute to joint tissue degeneration (tendon, muscle, and cartilage) after rotator cuff tear. Understanding the spatial and temporal distribution of upregulated proteases after rotator cuff tear can best inform therapeutic treatments to prevent degeneration, which would result in improved surgical outcomes after rotator cuff tear re-attachment surgery. First, using a rat model of rotator cuff tear that has been shown to replicate degenerative damage seen in humans, we investigated active proteases in each joint tissue over time. Second, we designed a novel microfluidic device to fabricate uniformly sized microparticles that can be loaded with protease inhibitors for subsequent use in vivo. Also, we reinvented a currently available fluorogenic substrate assay for the detection of E-64 (a broad, small molecule cathepsin inhibitor), which was our desired therapeutic. Lastly, we tested our E-64 loaded microparticles system on supraspinatus tendon tissue in our rat model of rotator cuff tear as a test bed to elucidate the effect of sustained release of a broad cathepsin inhibitor on active proteases.
dc.description.degree Ph.D.
dc.format.mimetype application/pdf
dc.identifier.uri http://hdl.handle.net/1853/63629
dc.language.iso en_US
dc.publisher Georgia Institute of Technology
dc.subject Rotator cuff
dc.subject Protease
dc.title Development of a controlled-release platform for investigation of proteases following rotator cuff tear
dc.type Text
dc.type.genre Dissertation
dspace.entity.type Publication
local.contributor.advisor Temenoff, Johnna S.
local.contributor.corporatename Wallace H. Coulter Department of Biomedical Engineering
local.contributor.corporatename College of Engineering
relation.isAdvisorOfPublication 16c04d46-3ad6-4fe8-bbe0-51cef9f71322
relation.isOrgUnitOfPublication da59be3c-3d0a-41da-91b9-ebe2ecc83b66
relation.isOrgUnitOfPublication 7c022d60-21d5-497c-b552-95e489a06569
thesis.degree.level Doctoral
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
TREVINO-DISSERTATION-2020.pdf
Size:
83.61 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
LICENSE.txt
Size:
3.86 KB
Format:
Plain Text
Description: